Development of antibody prodrug conjugates activated by legumain [electronic resource] / Hans-Georg Lerchen.
Material type:![Film](/opac-tmpl/lib/famfamfam/VM.png)
Animated audio-visual presentation with synchronized narration.
Title from title frames.
Contents: Modular composition of antibody drug conjugates -- ADC mode of action -- TWEAK receptor as an ADC target -- Improvements to achieve stable antibody conjugation -- KSP inhibitors as ADC toxophores -- Legumain-cleavable antibody prodrug conjugates -- Conceptualization of Antibody Prodrug Conjugates (APDCs) to increase the therapeutic window.
Access restricted to subscribers.
Mode of access: World Wide Web.